Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $152.82, giving the company a market capitalization of 377.7B. It carries a P/E multiple of 125.05 and pays a dividend yield of 2.15%.
During the trading session on 2026-08-26, Merck(MRK) shares reached a daily high of $156.34 and a low of $152.56. At a current price of $152.82, the stock is +0.2% higher than the low and still -2.3% under the high.
Trading activity shows a volume of 8.63M, compared to an average daily volume of 13.9M.
The stock's 52-week range extends from a low of $77.58 to a high of $156.92.
The stock's 52-week range extends from a low of $77.58 to a high of $156.92.
MRK News
On 19 August 2026, Merck & Co. and Moderna reported that their individualized mRNA-based neoantigen therapy intismeran, combined with Keytruda, achieved positiv...
Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200? By David Moadel Published Aug 25, 3:51PM EDT Quick Read MRK surged 45% year...
Biotech firm Moderna (MRNA) saw its stock rise 12.5% today, building on a multi-day rally after releasing positive Phase 3 trial data for its personalized mRNA...
Analyst ratings
68%
of 31 ratingsMore MRK News
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned. By Trey Thoelcke Published Aug 25, 7:15AM EDT Quick Read MRK and MRNA's intis...
Wolfe Research analyst Alexandria Hammond raised the firm’s price target on Merck (MRK) to $180 from $155 and keeps an Outperform rating on the shares. The firm...
Merck stock has delivered a strong 130.2% return over the past 5 years, yet its valuation picture is split, with a Discounted Cash Flow (DCF) estimate pointing...
Top Biopharma Analyst Sees Biotech M&A Market Reopening After a Long Freeze By Thomas Richmond Updated Aug 24, 6:17PM EDT · Published Aug 24, 8:59AM EDT Quick...
Services sectors in the US and Eurozone are still growing, while inflation worries keep central banks cautious and bond yields volatile. That mix can reward com...
Tempus AI (TEM +9.06%) stock posted massive gains this week despite valuation pressures across the broader market. The healthcare artificial intelligence (AI) s...
Merck & Company ( (MRK) ) has risen by 12.19%. Read on to learn why. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks Premium...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.